Stanford researchers have developed a targeted therapy for Alzheimer's disease that focuses on inhibiting the spread of tau protein, a key factor in disease progression.
Stanford researchers have developed a genetic strategy using antisense oligonucleotides (ASO) to reduce the levels of PCDH19 in human forebrain neurons, as a therapeutic approach for PCDH19-related encephalopathy.
Stanford scientists have developed a method to detect reactivated human herpesvirus 6 (HHV-6) in T cell therapies using genomics technologies, including single-cell sequencing.
Researchers at Stanford Genome Technology Center have patented a highly sensitive and specific straightforward circular Proximity Ligation Assay (c-PLA) method to reduce background and improve quantitative detection of protein biomarkers through conversion into unique DNA sequ
Stanford researchers in the Quake Lab have patented methods to apply DNA sequencing to analyze the variable regions of the antibody heavy chain in order to profile immune diversity in zebrafish.
Stanford scientists have discovered that certain immune receptors become more active in hematopoietic stem cells with age. This change leads to increased production of myeloid cells in the bone marrow.
Stanford scientists have developed novel polyacrylamide-based copolymers that exhibit antimicrobial activity against both Gram-negative and Gram-positive bacteria through a membrane disruption mechanism.
Stanford researchers in the Cargnello Lab have developed a new energy efficient method of converting lithium precursors, such as lithium chloride or lithium sulfate, to battery-ready lithium products, such as lithium hydroxide or lithium carbonate.
Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.
Stanford researchers have developed a novel approach to ultrasound imaging using the differentiable beamforming pipeline, which optimizes critical imaging parameters, significantly enhancing image quality and diagnostic accuracy in ultrasound imaging.
Stanford researchers at the de la Zerda Lab have developed an innovative alignment methodology using Optical Coherence Tomography (OCT) in conjunction with histopathology to diagnose cancer or determine tumor margins.